Breakingviews TV: Flabby activism

Starboard has produced a 197-page deck to support its opposition to Bristol-Myers’ $74 bln offer for Celgene. Antony Currie and Rob Cyran highlight the presentation’s contradictions and misplaced micromanagement that undermine Starboard’s case.

from Reuters Video: Breakingviews https://ift.tt/2FmPZsK
via IFTTT